Johnson & Johnson Surpasses Expectations, Raises 2025 Guidance Amid Strong Medtech Growth
Johnson & Johnson reported a strong Q2 performance, exceeding market expectations and raising its full-year guidance for 2025, driven by growth in its medtech business.
2 minutes to read